Shorter antibiotic course for lyme rash put to the test
NCT ID NCT03966014
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two treatment plans for people with erythema migrans, the classic Lyme disease rash. One group takes amoxicillin for 10 days, another for 14 days, and a third group gets no treatment. The goal is to see if a shorter course works just as well at preventing later symptoms. About 200 adults with the rash are being enrolled.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
amoxicillin
What this could lead to
If it works, this could show that a shorter course of amoxicillin is just as effective as a longer one for treating early Lyme disease.
What could go wrong
This is a moderate-sized trial, and the results may not apply to people with more advanced Lyme disease or other health conditions. Some patients may still have lingering symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ERYTHEMA MIGRANS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Medical Centre Ljubljana
RECRUITINGLjubljana, Slovenia
-
University Medical Centre Ljubljana
NOT_YET_RECRUITINGLjubljana, Slovenia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••